Oxolane-3-sulfonamide - CAS 1311316-50-3
Catalog: |
BB058432 |
Product Name: |
Oxolane-3-sulfonamide |
CAS: |
1311316-50-3 |
Synonyms: |
Tetrahydro-3-furansulfonamide |
IUPAC Name: | oxolane-3-sulfonamide |
Description: | Oxolane-3-sulfonamide is used in preparation of Azabicycloheptanyloxymethyl Pyrazoles, Triazoles and related compounds; which are used as hormone receptor modulators treatment and prevention of FXR-mediated diseases. Also, used in preparation of N-Sulfonylated pyrazolo[3,4-b]pyridine-6-carboxamides as CFTR modulators. |
Molecular Weight: | 151.18 |
Molecular Formula: | C4H9NO3S |
Canonical SMILES: | C1COCC1S(=O)(=O)N |
InChI: | InChI=1S/C4H9NO3S/c5-9(6,7)4-1-2-8-3-4/h4H,1-3H2,(H2,5,6,7) |
InChI Key: | GMAXVRALICXRLK-UHFFFAOYSA-N |
References: | Chao, J., et al. PCT Int. Appl., (2019); Akkari, R., et al. PCT Int. Appl., (2017). |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2019084300-A1 | TREATMENT OF GLIOBLASTOMA WITH FASN INHIBITORS | 20171025 |
US-2021380585-A1 | Hormone receptor modulators for treating metabolic mutagenic and fibrotic conditions and disorders | 20170914 |
US-2019233420-A1 | Hormone receptor modulators for treating metabolic conditions and disorders | 20160823 |
US-10793568-B2 | Hormone receptor modulators for treating metabolic conditions and disorders | 20160823 |
US-2021017177-A1 | Hormone receptor modulators for treating metabolic conditions and disorders | 20160823 |
AU-2016333856-A1 | N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use | 20151009 |
US-10259810-B2 | N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use | 20151009 |
US-10647717-B2 | N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of use | 20151009 |
US-2017101405-A1 | N-SULFONYLATED PYRAZOLO[3,4-b]PYRIDIN-6-CARBOXAMIDES AND METHOD OF USE | 20151009 |
US-2018105522-A1 | N-SULFONYLATED PYRAZOLO[3,4-b]PYRIDIN-6-CARBOXAMIDES AND METHOD OF USE | 20151009 |
Complexity: | 181 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 151.03031432 |
Formal Charge: | 0 |
Heavy Atom Count: | 9 |
Hydrogen Bond Acceptor Count: | 4 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 151.03031432 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 77.8Ų |
Undefined Atom Stereocenter Count: | 1 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | -1 |
-
Catalog: BB055796
(-)-(1S,2R)-1,2-Dihydro-1,2-naphthalenediol
Detail
-
Catalog: BB054889
(+)-(2S,5R)-1-Allyl-2,5-dimethylpiperazine, (+)-Camphoric Acid Salt
Detail
-
Catalog: BB058457
((R)-5-Oxopyrrolidine-2-carbonyl)-L-glutamic Acid
Detail
-
Catalog: BB069213
(-)-(18-Crown-6)-2,3,11,12-tetracarboxamide
Detail
-
Catalog: BB055501
(-)-Camphenilone
Detail
-
Catalog: BB064048
(-)-Huperzine A-d6 (Major)
Detail
-
Catalog: BB072005
(+)-(3-Bromopropyl)boronic Acid Pinanediol Ester
Detail
-
Catalog: BB056914
(-)-(2S,3S)-Viridifloric Acid Acetonide
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS